Table 4 Unadjusted and Adjusted Associations of sxKOA and 8-Foot Walk with Incident CVD
From: Contributions of symptomatic osteoarthritis and physical function to incident cardiovascular disease
Variable | Unadjusted | Model 1a | Model 2a |
|---|---|---|---|
OR (95% CI) | OR (95% CI) | OR (95% CI) | |
Baseline 0.3Â m/s (1SD) decrease in mean 8Â ft. walk speed among those without sxKOA | 1.46 (1.23, 1.74) | 1.64 (1.35, 1.99) | 1.46 (1.17, 1.82) |
Baseline 0.3Â m/s (1SD) decrease in mean 8Â ft. walk speed among those with sxKOA | 0.91 (0.62, 1.33) | 0.99 (0.67, 1.47) | 0.90 (0.59, 1.36) |
Worsened 8Â ft. walk vs. unchanged or improved | 1.12 (0.87, 1.45) | 1.53 (1.15, 2.04) | 1.47 (1.07, 2.01) |
Age: 1Â year increase | Â | Â | 1.01 (0.99, 1.03) |
Gender: Female vs. Male | Â | Â | 1.35 (0.96, 1.91) |
Race: Black vs. White | Â | Â | 1.05 (0.77, 1.44) |
Education: <HS vs. HS or greater | Â | Â | 0.92 (0.66, 1.27) |
Cohort: Enrichment vs. Original | Â | Â | 1.10 (0.79, 1.54) |
BMI: 1Â kg/m2 increase | Â | Â | 0.98 (0.96, 1.01) |
WHR: 0.1 unit increase | Â | Â | 1.15 (0.98, 1.36) |
Diabetes vs. not | Â | Â | 1.80 (1.19, 2.71) |
Hypertension vs. not | Â | Â | 1.11 (0.83, 1.49) |
High cholesterol vs. not | Â | Â | 1.09 (0.79, 1.52) |
NSAIDs vs. not | Â | Â | 1.34 (1.00, 1.80) |